ロード中...
Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
AIM: The aim of this study was to perform a cost-effectiveness analysis to establish the cost-effectiveness of sensor-augmented pump therapy (SAP) with automated insulin suspension vs continuous subcutaneous insulin infusion (CSII) alone in patients with type 1 diabetes in the Netherlands. PATIENTS...
保存先:
| 出版年: | Clinicoecon Outcomes Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6336135/ https://ncbi.nlm.nih.gov/pubmed/30679914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S186298 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|